Names and pronunciation
(mox-e-toom′oh-mab pa- soo′doe-tox) Lumoxiti
PDF page 917
Loading InternPractice…
Drug reference
(mox-e-toom′oh-mab pa- soo′doe-tox) Lumoxiti
PDF page 917
Func. class.: Antineoplastic
PDF page 917
USES: Relapsed or refractory hairy- cell leukemia in patients who have received at least 2 prior systemic thera- pies, including treatment with a purine nucleoside analog
PDF page 917
CONTRAINDICATIONS: Hyper- sensitivity
PDF page 917
Black Box Warning: Capillary leak syn- drome, hemolytic-uremic syndrome
PDF page 917
DOSAGE AND ROUTES • Adult: IV 0.04 mg/kg (actual body weight) over 30 min on days 1, 3, and 5 repeated q28days until disease progres- sion or a maximum of 6 cycles
PDF page 917
Available forms: Powder for injection 1 mg
PDF page 917
• Adult: IV 0.04 mg/kg (actual body weight) over 30 min on days 1, 3, and 5 repeated q28days until disease progres- sion or a maximum of 6 cycles
PDF page 917